We move satisfactorily in the collaboration with the regions in the medical-pharmaceutical issue, specifically the introduction of Heberprot P in pilot studies, Cuban ambassador, Emilio Lozada, said in an interview with Prensa Latina.
Lozada recalled that the medicine, unique in the world prescribed for treating diabetic foot ulcer, was registered in Russia in February 2014, and then included in the list of Essential and Vital Medicines within the Federation, earlier this year.
Pilot studies have been successfully developed in the region of Kaluga, Nizhny Novgorod, Sverdlovsk, and Kursk, with prospects of extending the clinical trials to other regions, such as Tver, Tula, Oriol, Ivanovo, Rostov, and Irkutsk, in Siberia.
The diplomat said about this issue that a seminar for about 200 Russian doctors was held with that purpose in Oriol on the application instruction of the biopharmaceutical medicine, which have been also experimentally carried out in the republics of Tatarstan and Bashkotarstan, according to the source.
Lozada stressed the progress reached in recent years in promoting the Cuban tourism products in St. Petersburg, Russiaâ�Ös second largest city, where the opening in the coming months of a Havanatur subsidiary company is expected.
Negotiations with the Sverdlovsk region and the republic of Tatarstan are also strengthened. Along with the pharmaceutical products and services, tourism is a pivot to boost trade and business relations with the regions, the ambassador said.

Twitter